Estrogens can regulate germ cell function. Estrogen action is mediated via high affinity ERs; two subtypes (ER␣ and ER␤) have been identified. We have shown previously that ER␤ is expressed in nuclei of multiple human testicular cells. A variant isoform of human (h) ER␤ (hER␤cx/2), formed by alternative splicing, has been identified in testicular cDNA libraries by two laboratories. The present study examined the expression of wild-type (ER␤1) and variant (ER␤2) ␤ receptors in human testes by 1) RT-PCR with isoform specific primers, and 2) single and double immunohistochemistry using monoclonal antibodies raised against peptides unique to the C termini of hER␤1 and hER␤2. PCR products specific for ER␤1 and ER␤2 were amplified from cDNA pools prepared from human testes and granulosa cells. On Western blots, the anti-ER␤1 monoclonal antibody bound to recombinant ER␤1 and the anti-ER␤2 monoclonal to recombinant hER␤2. Neither bound to the other ER␤ isoform nor to recombinant ER␣. ER␤1 and ER␤2 proteins were both detected in human testis. Immunoexpression of ER␤1 was most intense in pachytene spermatocytes and round spermatids, whereas low levels of expression were detected in Sertoli cells, spermatogonia, preleptotene, leptotene, zygotene, and diplotene spermatocytes. Highest levels of expression of ER␤2 protein were detected in Sertoli cells and spermatogonia with low/variable expression in preleptotene, pachytene, and diplotene spermatocytes. 
I
T HAS BEEN proposed that estrogens may play a role in regulating spermatogenesis (see review by Ref. 1). For example, Ebling et al. (2) found estrogen treatment of hpg mice stimulated spermatogenesis and Pentikainen et al. (3) reported that estrogen exposure reduced levels of germ cell apoptosis in isolated human seminiferous tubules consistent with estrogen acting as a germ cell survival factor. The biosynthesis of estrogens from androgens is catalyzed by the aromatase complex. Levels of estrogen within the male reproductive tract are higher than in the general circulation consistent with production of estrogens (reviewed in Ref. 4 ). In the adult testis, the major site of aromatase expression appears to be the Leydig cells (5, 6) ; however, aromatase activity has also been detected within mature germ cells and spermatozoa (6 -8) . Male mice in which estrogen biosynthesis is impaired due to targeted disruption of the aromatase gene (ARKO) become infertile (9) . Analyses of the testes of these animals has shown that round spermatids undergo apoptosis, show disturbances in acrosome formation, and fail to differentiate into mature elongate spermatids (9, 10) . Consistent with estrogens acting as a germ cell survival factor treatment of monkeys with an aromatase inhibitor also results in a reduction in the progression of round to elongate spermatids (11) .
Estrogen action is mediated via high affinity receptors that are shifted to a transcriptionally active state after ligand binding. Two forms of ER commonly known as ␣ (ER␣, NR3A1) and ␤ (ER␤, NR3A2) have been cloned from human (h) (12) (13) (14) and other species (15, 16) . Both receptors are encoded by eight exons and are the products of two genes located on different chromosomes (17) . Phylogenetic analysis suggests that they arose from a single duplication event at least 450 million years ago (18) . Like other members of the steroid receptor superfamily, ER␣ and ER␤ share a common arrangement of five structure-function domains, denoted A to F (19) . Key domains include the DNA binding domain (C), two transactivation domains [activation function (AF)-1 and AF-2, located in the N (A/B domain) and C-terminal (E/F domain) portions of the protein, and regions within the C and E domains involved in receptor dimerization (see reviews in Refs. 20 and 21) . Studies in vitro have demonstrated that homodimers (ER␣-ER␣ or ER␤-ER␤), or heterodimers (ER␣-ER␤), can be formed when both isoforms are expressed in the same cell (22, 23) . In 1998, a novel human ER␤ variant, named hER␤cx, was identified by screening a human testis cDNA library (Ref. 24 ; GenBank accession no. AB006589). The open reading frame of the protein was predicted to be identical to that of full-length hER␤ (59 kDa, Ref. 14, GenBank accession AB006590) except for a truncation at the C-terminus leading to the loss of 61 amino acids. The C-terminus of hER␤cx was found to encode a unique 26 amino acid peptide, resulting in a protein containing 495 amino acids (ϳ55 kDa). In a separate series of experiments, Moore et al. (25) identified mRNAs encoding both this isoform of hER␤, which they called hER␤2 (GenBank accession no. AF051428), as well as three further isoforms, which they named ER␤3, ER␤4, and ER␤5 in human tissues including testis. They showed that the ER␤2 variant could bind DNA both as a homodimer and as a heterodimer with hER␤1 using gel shift assays. For the rest of this paper, the hER␤ protein identified initially as the homolog to rat ER␤ (13, 14, 17) will be referred to as ER␤1 and the ER␤cx/ER␤2 variant as ER␤2 to distinguish them from each other. Note that the human ER␤2 cloned by Lu et al. (GenBank accession no. AF124790) is not the same variant as the ER␤cx/␤2 described above, but a form of ER␤ that lacks exon 5; this variant encodes a truncated ER␤ protein lacking the entire ligand binding domain (26) . A splice variant isoform of ER␤ has also been identified in rodents and is sometimes referred to as ER␤2, or more recently as ER␤ins (27) (28) (29) . This variant is not identical to hER␤2 but contains a 54-bp insertion within the ligand binding domain (domain E) leading to the addition of 18 amino acids, this isoform has not been detected in human cDNAs prepared from normal human ovary, endometrium, mammary gland (30, 31) or testis (our unpublished observations).
We have shown previously using both immunohistochemistry and Western blotting that ER␤ protein is widely expressed in the testis and reproductive system of the human, primate, and rodent (32) (33) (34) . However, the antibody used for those studies was raised against a peptide (P4) (35) in the D domain of hER␤ that is identical in both hER␤1 and hER␤2. We have recently confirmed that this antibody is capable of recognizing both these isoforms of ER␤ on Western blots (Scobie, G. S., and P. T. K. Saunders, unpublished observations). As ER␤2 was originally isolated from human testis cDNA libraries, and has been proposed to act as a negative regulator of ER activity (24), we have extended our investigations using monoclonal antibodies specific for ER␤1 and ER␤2. We show for the first time that both ER␤1 and ER␤2 proteins are expressed in multiple cell types within the human testis but that their patterns of expression are distinct.
Materials and Methods

Tissue samples
Testicular tissues were obtained from men (n ϭ 10) undergoing surgical investigations for nonobstructive azoospermia or surgical correction of vasectomy. The Lothian Reproductive Medicine Ethics committee approved the protocols, and men gave informed consent. Additional human tissues (n ϭ 6) were obtained from the Peterborough Hospitals NHS Trust tissue bank. Samples for immunohistochemistry were fixed in Bouins for 6 -7 h and processed into paraffin wax using standard methods (36) . A sample of RNA extracted from human granulosa cells was a gift from Dr. Chris Harlow (Edinburgh University) human endometrial tissue was a gift from Prof. Hilary Critchley (Edinburgh University). Tissues for RNA extraction were snap frozen on dry ice or in liquid nitrogen and stored at Ϫ70 C before use.
Analysis of ER␤ mRNAs by RT-PCR
Frozen tissue samples (testicular biopsy and endometrium) were ground up under liquid nitrogen using a pestle and mortar, divided into approximately 50 mg samples, and stored at Ϫ70 C. RNA was extracted using Tri Reagent (Sigma, Poole, Dorset, UK) according to manufacturer's instructions, dissolved in ribonuclease-free water and 5 g total RNA subjected to reverse transcriptase using Expand Reverse Transcriptase (Roche Lewes, Sussex, UK) and an oligo deoxythymidine primer according to the instructions supplied with the enzyme. Firststrand cDNA was purified by heating to 100 C for 5 min, ribonuclease treatment at 37 C for 15 min, and finally by passing through a "High Pure PCR Purification" column (Roche). Purified cDNAs were quantified on Amersham Pharmacia Biotech Genequant (St. Albans, Hertfordshire, UK) and adjusted to a final concentration of 5 ng/l in Tris/EDTA buffer (10 mm Tris/HCl, pH 7.5; 1 mm EDTA).
PCRs were performed using AGS Gold Taq (Hybaid, Ashford, Middlesex, UK) with the following primers: ER␤ common 5Ј primer (exon 7) 5Ј-GGCATCTCCTCCCAGCAGCA was used in combination with either a specific ER␤1 3Ј primer 5Ј CACTGAGACTGTGGGTTCTGGGA (amplified product 261 bp) or a specific ER␤2 3Ј primer 5Ј-CACTGCTCCATCGTT-GCTTC (amplified product 156 bp). ER␣ cDNA was amplified with primers identical to ER␣ specific set 1 (exon 1-3) published previously by Lau et al. (37) (amplified product 650 bp). Internal GAPDH primers were 5Ј-GAACGGGAAGCTCACTGGCAT and 5Ј-GTCCACCACCCTGTTGCTG-TAG (amplified product 301 bp). PCR conditions were as follows: 1 cycle of 94 C for 2 min followed by 30 cycles of 94 C for 30 sec, 58 C for 30 sec and 72 C for 30 sec, with a final cycle of 72 C for 10 min, in a 0.2-ml Hybaid Sprint thermal cycler. PCR products were separated on 2% agarose gels stained with ethidium bromide and then photographed.
Antibodies
Peptide P7 (CSPAEDSKSKEGSQNPQSQ) specific for hER␤1 (wild-type, Refs. 14 and 17, GenBank accession no. AB006590) and peptide P8 (CMK-METLLPEATMEQ) specific for hER␤2 (Refs. 24 and 25; GenBank accession no. AB006589) were synthesized in the Center for Proteins and Peptides, Oxford Brookes University and conjugated to tuberculin. Conjugated peptides were used to immunize individual mice and monoclonal antibodies prepared according to standard methods (38) . Positive clones directed against ER␤1 and ER␤2 were identified by ELISA using recombinant human ER␤1 (P2466, PanVera, Madison, WI) or unconjugated peptide P8, respectively. Individual immunoglobulins (anti-ER␤1 type IgG2a; anti ER␤2 type IgG1) were purified from culture media that had been dialyzed against 10 mm phosphate buffer (pH 7.2) using Hi-trap protein G Sepharose columns according to the manufacturer's instructions (Amersham Pharmacia Biotech). The isolated IgGs were desalted on P10 columns (Amersham Pharmacia Biotech) that had been preequilibrated in PBS (pH 7.4) then mixed with 20% vol/vol glycerol and 0.02% wt/vol sodium azide (Sigma) and stored as 100 l aliquots at Ϫ20 C. The ability of the antibody directed against peptide P7 to detect expression of ER␤ in ovarian sections from human and marmoset monkey has been reported previously (35) .
Preparation of recombinant ER␤2
A full-length cDNA encoding hER␤2 was amplified from human testis cDNA prepared as described for RT-PCR analysis, using extensor Hi-Fidelity PCR master Mix (ABgene, Epsom Surrey, UK) and 0.6 m of each primer (5Ј ATG primer: 5Ј-GACATGGATATAAAAAACTCACC and 3Ј primer 5Ј-CACTGCTCCATCGTTGCTTC). PCR cycle conditions were: 1 cycle of 94 C for 2 min followed by 30 cycles of 94 C for 30 sec, 58 C for 30 sec and 72 C for 90 sec, with a final cycle of 72 C for 10 min. The resulting cDNA was cloned in frame into the pUni donor vector (pUni/V5-His-TOPO Echo Cloning System) according to the manufacturer's instructions (Invitrogen, Breda, The Netherlands). The full-length pUNI/␤2 cDNA construct was recombined into the pRSET-E acceptor Echo bacterial expression vector (Invitrogen) by incubation of the donor/acceptor plasmids in the presence of CRE-recombinase according to the protocol supplied by Invitrogen, transformed into TOP10 cells, and selected on kanamycin agar plates. Recombinant hER␤2 protein was made by transforming the pRSETB2 plasmid into BL21(DE3)plysS (Invitrogen) and growing the transformed bacteria in LB-medium containing 1 mm IPTG for 2-3 h. Bacterial cells were separated by centrifugation and the resulting pellets were boiled in 1ϫ lysis buffer (contains 50 mm Tris/HCl, pH 6.8; 100 mm dithiothreitol; 2% SDS; 10% glycerol; and 0.1% bromophenol blue).
Western analysis
Recombinant human ER␤1 corresponding to short (ϳ53 kDa) and long (ϳ59 kDa) forms of the wild-type form of the receptor (ER␤1; 13, 14) as well as full-length ER␣ were obtained from PanVera (Madison WI). Recombinant ER␤2 was prepared as above. Recombinant proteins (0.1 g/lane ER␤1L, ER␤S, and ER␣ or 10 l lystate ER␤2) and prestained protein molecular weight markers (Bio-Rad Laboratories, Inc., Hercules, CA) were separated on denaturing minigels containing an acrylamide gradient from 4 to 20% (wt/vol) polyacrylamide (Invitrogen) using Tris/glycine/SDS running buffer (25 mm Tris; 250 mm glycine, pH 8.3; 0.1% SDS). Proteins were transferred to immobilon membrane using a Tris/glycine buffer (12 mm Tris; 96 mm glycine, pH 8.3). Membranes were incubated overnight with the mouse monoclonal antibodies at 1 in 500 diluted in Tris-buffered saline (TBS)-Tween buffer (10 mm Tris; 150 mm NaCl; 0.05% Tween-20) containing 5% dried milk. Bound antibodies were detected using a horseradish peroxidase (HRP)-conjugated rabbit antimouse IgG and the electrochemiluminescence visualization system (Amersham Pharmacia Biotech) according to the manufacturer's instructions.
Immunohistochemistry
Immunolocalization of ER␤1 and ER␤2 used 5 m paraffin tissue sections which were subjected to heat induced antigen retrieval (39) in a pressure cooker (Tefal, Nottingham, UK) containing 2 liters of near boiling 0.01 m glycine/EDTA, pH 3.5. Thereafter, the sections were washed and endogenous peroxidase blocked as described previously (33) . Mouse anti-ER␤1 (monoclonal 9) and anti-ER␤2 (monoclonal 57/3) were each diluted 1 in 50 in normal rabbit serum (NRS, Diagnostics Scotland, Edinburgh, UK) diluted 1:4 in TBS (0.05 m Tris, pH 7.4; 0.85% saline) containing 5% BSA (NRS/TBS/BSA). Antibodies were incubated on sections overnight at 4 C. Sections were washed twice for 5 min each time in TBS and incubated with biotinylated rabbit-antimouse IgG (DAKO Corp., Cambridge, UK) diluted 1:500 in NRS/TBS/BSA. Incubations lasted for 1 h and were followed by two washes in TBS (5 min each). Thereafter, sections were incubated in avidin-biotin complex-HRP (DAKO Corp.) for 1 h, washed in TBS (2 ϫ 5 min) and bound antibodies visualized by incubation with liquid 3,3Ј-diaminobenzidine tetra-hydrochloride (catalog no. K3468, DAKO Corp.). Sections were counterstained lightly with hematoxylin to enable identification of cell nuclei containing low levels of immunopositive staining. Staining of sections was repeated at least twice; sections were then examined independently by two individuals and the identity of immunopositive cells and the intensity of immunostaining noted on a stage diagram of human spermatogenesis (see Ref. 40) . Images were captured using an Olympus Corp. Provis microscope (Olympus Corp. Optical Co., London, UK) equipped with a Kodak DCS330 camera (Eastman Kodak Co., Rochester, NY), stored on a Macintosh PowerPC computer and assembled using Photoshop 5.5 (Adobe, Mountain View, CA).
Double fluorescent immunohistochemistry
Sections were washed, subjected to antigen retrieval, and blocked as described above. Washes detailed below were for 5 min each, and incubations were at room temperature unless otherwise specified. Mouse anti-ER␤1 specific was diluted 1 in 20 in NRS/TBS/BSA (see above) and incubated on sections overnight at 4 C. Sections were washed, incubated with biotinylated rabbit antimouse IgG (DAKO Corp.) diluted 1 in 500 in NRS/TBS/BSA for 30 min then washed in TBS followed by PBS. The fluorochrome streptavidin 546 Alexafluor (Molecular Probes, Inc., Eugene, OR) diluted 1 in 200 in PBS was incubated on slides for 2 h. Sections were washed in PBS then TBS, incubated with biotin (4 drops/1 ml TBS) for 10 min, re-washed twice in TBS, and incubated with normal mouse IgG diluted 1 in 1000 in NRS/TBS/BSA for 30 min. Sections were reblocked with NRS/TBS/BSA for 30 min then incubated with mouse anti-ER␤2 diluted 1 in 50 in NRS/TBS/BSA overnight at 4 C. Sections were washed twice in TBS, incubated with HRP conjugated rabbit-antimouse IgG1 subtype specific antiserum (Zymed Laboratories, Inc., South San Francisco, CA) diluted 1 in 100 in NRS/TBS/BSA for 1 h. Sections were washed in TBS containing 0.1% Tween followed by TBS and incubation with Tyr-Cy5 (from kit NEL745, NEN Life Science Products) for 10 min, which produced and enhanced the second fluorescent signal. Sections were washed and mounted in Permafluor (Immunotech-Coulter, High Wycomb, Buckinghamshire, UK). Fluorescent images were captured on a Carl Zeiss (Jena, Germany) laser scanning microscope LSM 510. The alexafluor 546 was detected using the helium/neon 1 laser (excitation beam, 543 nm) and an emission band pass filter 560 -615 nm. The Cy 5 was detected with the helium/ neon 2 laser (excitation beam 633 nm) and emission long band pass filter 650.
Results
Detection of both ER␤1 and ER␤2 in testicular samples
cDNAs specific for both ER␤1 and ER␤2 isoforms were amplified from cDNA prepared by RT of total RNA from human testis obtained from BD Biosciences Clontech (Palo Alto, CA) (Fig. 1, lanes 1 and 2) or prepared from a human testicular biopsy (Fig. 1, lane 9) , human granulosa cells (Fig. 1, lane 5) or human endometrium (Fig. 1, lane 8) . Both isoforms were identified in a cDNA library obtained from Stratagene (La Jolla, CA) (lane 4) and a pool of marathonready cDNAs prepared from human testes by BD Biosciences Clontech (lane 3). In all samples, the amount of the ER␤1 cDNA amplified appeared to be slightly higher than that of ER␤2; this difference was most marked in the Stratagene cDNA library and in granulosa cells but was not quantified. When the same panel of samples was tested using ER␣-specific primers (Fig. 1C) 
Specificity of ER␤ monoclonal antibodies
On Western blots, the monoclonal antibodies directed against peptides at the C termini of ER␤1 or ER␤2 recognized the appropriate full-length recombinant proteins (Fig. 2, A and B) but did not cross-react either with the alternative isoform nor with recombinant ER␣ (lane ␣). Absorption with the immunizing peptide abolished the positive reaction (not shown).
Immunoexpression of ER␤1 and ER␤2 in adult human testis
Although proteins recognized by the monoclonal antibodies specific for ER␤1 and ER␤2 were expressed in multiple cell nuclei within the human seminiferous epithelium, their pattern of expression was strikingly different (Fig. 3, a and  b) . The most intense immunostaining for ER␤1 was detected in round spermatids (R, Fig. 3, c and e, g ), but this was lost as they started to undergo nuclear condensation (Fig. 3e, s4) . Round spermatids were immunonegative or very slightly immunopositive for ER␤2 (Fig. 3d, R) . ER␤1 and ER␤2 proteins were not detected in elongate spermatids (E). Pachytene spermatocytes (P) contained intense immunopositive staining for ER␤1 (Fig. 3e) but stained only slightly when incu-bated with ER␤2 monoclonal (see Fig. 3 , b and f, labeled P), whereas diplotene pachytene spermatocytes contained low levels of both proteins (Fig. 3, labeled D) . All A type spermatogonia contained ER␤1 and ER␤2; immunoexpression of ER␤2 was generally more intense and was particularly striking in B type spermatogonia (Fig. 3f, arrows) . A clear differential was seen between the levels of expression of the isoforms within Sertoli cell nuclei (arrowheads); ER␤1 was low/ barely detectable (Fig. 3, c and e, g ) but staining for ER␤2 was intense (Fig. 3, d and f, h ). Low and variable levels of expression of both isoforms were detected in peritubular myoid and Leydig cells.
Fluorescent immunohistochemistry
Colocalization of ER␤1 and ER␤2 on the same sections of human testes proved technically challenging because both antibodies were raised in mouse and the fluorescent detection systems were less sensitive than those using color endpoints. Results obtained (Fig. 4) confirmed and extended results of single immunohistochemistry. For example, Sertoli cell nuclei (arrowheads) were clearly stained blue (ER␤2 positive), in contrast round spermatids (R) were red (ER␤1 positive). Other cell types including pachytene spermatocytes (P, red with a few flecks of blue), spermatogonia (arrows, blue with a few flecks of red) and peritubular myoid cells (ptm, blue or * red/blue) expressed both receptors in variable proportions.
Summary of patterns of expression of ER␤1 and ER␤2
To provide a summary of the patterns of expression of the ER subtypes, the intensity of immunostaining observed (each antibody was used separately) on parallel sections of testes was scored on a scale of ϩ to ϩϩϩϩ. The results from multiple samples, all of which were stained two or more times were compared. A summary of the findings is presented in Fig. 5 ; the amount of shading correlates with the intensity of staining observed. For example, Sertoli cells (ϩϩϩ) and B type spermatogonia (ϩϩϩϩ) are strongly immunopositive for ER␤2, whereas the highest levels of expression of ER␤1 are observed in round spermatids (ϩϩϩϩ).
Discussion
In the present paper, we have investigated the pattern of expression of two isoforms of ER␤ (wild-type ER␤1 and variant ER␤2) in the human testis. These studies form part of continuing investigations into the impact of endogenous and exogenous estrogens on male reproductive health (see Refs. 42 and 43) for reviews.
Using RT-PCR with specific primers, both ER␤1 and ER␤2 cDNAs were detected in samples extracted from human testes, granulosa cells, endometrium (this paper), placenta, and human cell lines (44) . These results are in agreement with previous studies that have detected expression of ER␤1 and ER␤2 mRNAs in human testis extracts using PCR-based approaches (25, 45) . Specifically, Moore et al. (25) published results showing that the although the amounts of ER␤1 and ER␤2 cDNAs detected in a wide range of human tissues and cell lines varied considerably between samples, the amount of both appeared especially high in ovary and testis. Ogawa and co-workers (24) detected both an ER␤1 mRNA of approximately 7.5 kb and an ER␤2 mRNA of approximately 7 kb in testicular and ovarian samples on Northern blots purchased from BD Biosciences Clontech. Chu et al. (30) have used RT-PCR and Southern blotting to detect ER␤2/cx in normal human ovarian tissue extracts as well as those from a range of different ovarian tumors.
The same panel of samples were also analyzed using ER␣-specific primers and the amount of cDNA amplified found to be variable with no detectable signal in RNA from a testicular biopsy and low levels in cDNAs prepared from pooled testicular RNA purchased from BD Biosciences Clontech. We and others have failed to detect ER␣ protein within the adult human testis using immunohistochemistry or Western blotting (33, 45) , although the protein can easily be detected in Leydig cells of rodent testes examined using identical approaches (46) . High levels of expression of ER␣ protein have been detected in the efferent ductules and initial segment of the epididymis that lie adjacent to the testis (33, 46) . Our inability to detect ER␣ mRNA in testicular biopsy material removed from the organ in such a way as to avoid contamination with efferent ductule tissue leads us to the conclusion that the presence of ER␣ cDNAs in some cDNAs samples obtained from commercial sources may reflect contamination with nontesticular tissue.
Previous studies that have reported expression of ER␤ protein in adult human testes have used antibodies that either cross-react with both isoforms (33, 45, 47, 48 ) or should only bind to ER␤1 (3). In the present study, we found that the patterns of expression of ER␤1 and ER␤2 were distinct but overlapping. For example, although both receptors were detected in Sertoli cells and spermatogonia, immunoexpression of ER␤2 appeared to be more intense than that of ER␤1 in both of these cell types, although these results need to be treated with some caution as direct comparison of staining intensities can reflect differences in antibody affinity as well as antigen concentration. The opposite was true of the pachytene spermatocytes in which immunoexpression of ER␤1 was intense and expression of ER␤2 was low. Round spermatids expressed the highest levels of ER␤1 protein, and we rarely detected any evidence of expression of ER␤2 in these cells. Once the round spermatids started to condense (from stage IV onwards), expression of ER␤1 was lost. Using antibodies raised to peptides within the A/B and D domains of ER␤ (Ref. 33 ; and unpublished observations), we have detected immunopositive staining in multiple testicular cell types. Careful examination of the intensity of staining in the different cells suggests that in our previous experiments (33) the pattern of staining observed is consistent with simultaneous detection of ER␤1 and ER␤2 by the antibodies employed. Similar patterns of staining have been reported from most (45, 47) , but not all (48) , of the studies that have used antibodies likely to cross-react with both isoforms of ER␤. Pentikainen et al. (3) detected expression of ER␤ in zygotene and pachytene spermatocytes and in stage V spermatids in squash preparations from human testes using a polyclonal antibody raised against the C-terminal peptide of ER␤1; immunoexpression of ER␣ was detected in the same cells. These results are clearly at odds with our own findings using an ER␤1-specific monoclonal that we have shown does not cross-react with ER␤2 or ER␣ recombinant proteins. The differences in staining seen in the two studies may relate to the method of preparation of samples (squash vs. fixed sections) or to the specificity of the primary antibody used by Pentikainen et al. (3) . During the present study, we were unable to obtain sufficient fresh testicular biopsies to allow us to undertake Western blotting experiments. We have previously reported that proteins with molecular masses in the range 53-57 kDa were detectable in extracts from two human testicular biopsies using a polyclonal antibody that will cross-react with both ER␤1 and ER␤2 (33) . It is therefore possible that the smaller protein could either be the short form of ER␤1 (53 kDa) or ER␤2 (55 kDa), which we have successfully identified in nuclear extracts from human endometrial tissue on Western blots using the specific ER␤2 monoclonal antibody (Scobie, G., unpublished observations).
In considering how expression of ER␤2 might influence estrogen activation of gene expression in the human testis, it is useful to review the information available on the functional role of the region of ER␤1 that is not present in hER␤2 due to the presence of an ER␤2 specific exon 8 (24) . Briefly, in hER␤1 the wild-type exon 8 encodes part of domain E and all of domain F (amino acids 468 to 530, Ref. 14). Critical amino acids within this region include several involved in ligand binding that are conserved with ER␣, for example, ER␤ G472 (␣ G521), ER␤ H475 (␣ 524) and ER␤ L476 (␣ 525) (49 -51) . The AF-2 domain that includes the twelfth helix of the protein, is also encoded by exon 8 (hER␤1 amino acids 476 -500). Furthermore, the conformation adopted by helix 12 following ligand binding is critical in determining recruitment of cofactors to the ligand-receptor complex (see review by Ref. 52) . Consistent with the loss of these amino acids, Ogawa et al. (24) reported that when they transfected an ER␤2 construct into COS cells they were unable to detect binding of E2 to whole cell extracts and that ER␤2 was unable to induce expression of an ERE-CAT reporter construct in the presence or absence of E2. All but one of the amino acids identified as key to the dimerization of ERs (50, 53) are not encoded by exon 8 and are therefore identical in both ER␤1 and ER␤2. Consistent with the presence of both the DNA binding and dimerization domains, Moore et al. (25) used gel shift assays to demonstrate that ER␤2 bound to DNA containing a consensus ERE both as a homo-and as a heterodimer with either ER␣ or ER␤1. Ogawa et al. (24) found that ER␤2 was incapable of interacting with TIF1a, a coregulator that has been shown to interact with ligand-activated hER␣ via the AF-2 domain. Studies on murine ER␤ have shown that the absence of an intact AF-2 domain in one partner within the steroid receptor dimer is sufficient to impair transcriptional activity in the full-length heterodimeric partner (54) . When ER␤2 was cotransfected with ER␣ (ratios 1:100 to 1:1), it acted as a dominant negative inhibitor of ER␣-induced transactivation (24) , although, surprisingly, in similar assays cotransfection of ER␤2 with ER␤1 did not appear to have any affect on reporter gene activation in the presence of E2. Alternative splicing of exons at the 3Ј ends of other steroid hormone receptor superfamily members such as the glucocorticoid receptor (55) has been reported previously. Loss of the 50 amino acids from the C terminus of hGR␣ and their replacement with a novel 15 amino acid results in formation of an hGR␤ isoform that, like ER␤2, does not bind steroid (56) . hGR␤ has been shown to heterodimerize with hGR␣ and to act as a dominant negative regulator of hGR␣ activity (57) . Taken together with the limited data on ER␤2 from transfection studies (24) , these findings suggest that expression of ER␤2 in cells containing ER␤1 might impair gene activation by the wild-type receptor following ligand binding.
In the course of the present study, when we used primers specific for the 5Ј and 3Ј ends of ER␤1 and ER␤2 to amplify full-length cDNAs, as well as products of the expected size, we usually amplified shorter cDNA products. Sequencing of several of these confirmed that they lacked sequences corresponding to exon 5 but included those within exon 6 (our unpublished observations). ER␣ and ER␤ isoforms that contain exon 5 deletions have been identified previously in breast cancer cell lines and tumors (58 -60) . Inoue et al. (26) have identified ER␤1 transcripts lacking exon 5 (ER␤1⌬5) in human testis cDNA, and we have shown that ER␤2⌬5 transcripts are also formed. The loss of exon 5 results in introduction of a premature stop codon in exon 6; the protein formed from the ER␤1⌬5 and ER␤2⌬5 cDNAs should be identical. The ER␤1⌬5 and ER␤2⌬5 proteins would not be detected by either of the antibodies used in the current study, as their sequence does not include the peptides used for immunization. Hall and McDonnell (61) have demonstrated that, unlike ER␣, the A/B region of ER␤ does not contain a strong AF-1 domain, but instead they suggest this region might act as a repressor. The presence of intact AF-1 and DNA binding domains in both ER␤2, and in the exon 5 deleted variants, would be consistent with the in vitro data showing they can act as dominant negative receptors when cotransfected with wild-type ER␣ and/or ER␤ (24, 26) . We plan further studies to investigate whether ER␤2 can also inhibit transactivation by ER␤1 at AP-1 sites.
Based on the results from several studies including those in ␤ERKO mice (62) , it has been proposed that one of the physiological roles of ER␤ is to act as a negative regulatory partner for ER␣ (29, 61, 62) . It has been reported that the rodent ER␤ variant (ER␤ins), which has lower affinity for E2 than wtER␤, also acts as a dominant negative receptor when heterodimerized with wild-type ER␤ (28, 63) . Expression of ER␤ins in the rat mammary gland is up-regulated during lactation, and double immunohistochemistry has found the variant colocalized with ER␣ in up to 80% of the epithelial cells. Saji and colleagues (29) have proposed that expression of ER␤ins quenches ER␣ in these cells making them insensitive to estrogens. Expression of ER␤ins in the rodent testis has not been investigated to date, but we speculate that expression of ER␤2 in the human testis may play a similar role to that of ER␤ins in the rodent mammary gland and serve to protect cells from estrogen action. If this is the case, then in adult human testes both Sertoli cells and spermatogonia may be insensitive to estrogens as they express an excess of ER␤2 compared with ER␤1.
In conclusion, we have demonstrated that ER␤1, the functional wild-type receptor, and ER␤2, a splice variant receptor that lacks the ability to bind E2 or to recruit cofactors via the AF-2 domain, are both expressed in the human testis. We speculate that the expression of ER␤2 in some cells may affect their ability to respond to endogenous or exogenous estrogens. Expression of ER␤1 in pachytene spermatocytes and round spermatids would be consistent with evidence from rodent studies that points to estrogens having a direct impact on the survival and maturation of germ cells.
